Kjell-Erik Nordby, Chief Executive Officer
Mr. Nordby has been CEO of Weifa since February 2009, and as of June 2015 CEO of Vistin Pharma. He was Vice President Business Development at Photocure, a Norwegian biotech company. Previous experience includes several years at Alpharma, a leading international generic pharmaceutical company listed on NYSE. He held several top management positions in the company including Head of S&M North Europe Region and as Senior Director API Business Development. Mr. Nordby holds a Master's degree in Pharmacy and Master's degree in Business Administration.
Gunnar Manum, Chief Financial Officer
Mr. Manum joined Weifa as CFO in August 2014, and as of June 2015 as CFO of Vistin Pharma. He previously held the positions as CFO at Aqualis for 7 years, and prior to that he was a senior advisor at Handelsbanken Capital Markets, Corporate Finance, for 8 years. Mr. Manum has a wide ranging experience from several managerial positions within finance and accounting at Stolt Sea Farm and PWC, Australia. He holds a MCom in Finance and Accounting from the University of New South Wales, Sydney.
Valborg Godal Vold, VP Sales & Marketing
Ms. Godal Vold joined Weifa in October 2012 as Vice President B2B Sales & Marketing, and as of June 2015 as VP Sales & Marketing, Vistin Pharma. She is an experienced executive manager within the biotechnology and pharmaceutical industry. Ms. Godal Vold holds a BA in Biomedical Laboratory Science (BLS) and an Executive Master in Business & Administration from BI Norwegian Business School /ESCP-EAP Paris.
Liesl Hellstrand, VP HR & Organisation
Ms. Hellstrand joined Weifa as Vice President HR in January 2014, and as of June 2015 as VP HR & Organisation, Vistin Pharma. She previously held the position as VP HR of Jordan for five years, and prior to that she spent nine years in Hydro as VP HR in Oslo, and four years as Director HR at Volvo Car Corporation in Gothenburg, Sweden. Ms. Hellstrand holds a BSc in Human Resource Development and Labour Relations, specializing in Organization, from Uppsala University, Sweden.
Hilde Merete Hagen, VP Quality & Regulatory Affairs
Ms. Hagen joined Weifa in March 2015 as VP QA, and as of June 2015 as VP Quality & Regulatory Affairs, Vistin Pharma. She previously held the position as Head of Quality & Regulatory Affairs Global Omega-3 at Pronova BioPharma, where she has held several management positions within QA during her 20 years with the company. Ms. Hagen holds a Master of Science in Chemistry from the University of Oslo and a Master of Management from the Norwegian School of Management.
Erik Løkke-Øwre, VP Operations
Mr. Løkke-Øwre joined Vistin Pharma in October 2016 as VP Operations. He previously held the position as SVP Operations, Tech. and Supply chain at REC Solar ASA and prior to that held several senior management positions at Elkem, where he was employed for almost 20 years. Mr. Løkke-Øwre holds a Master of Management from BI Norwegian Business School.